Harvard Apparatus Regenerative Technology EBIT 2013-2025 | HRGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Harvard Apparatus Regenerative Technology ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Harvard Apparatus Regenerative Technology ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$138.3B
CVS Health (CVS)	$80.7B
Elevance Health (ELV)	$77.8B
Cencora (COR)	$57.7B
DiDi Global (DIDIY)	$28.9B
Labcorp Holdings (LH)	$20.6B
Natera (NTRA)	$20.3B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.9B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.6B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.8B
Avantor (AVTR)	$8.8B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$8B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B